Phase 2 Readout~quarter
Phase 2 Readout: tibulizumab
- Company
- Zura Bio Ltd (ZURA)
- Drug
- tibulizumab
- Indication
- autoimmune and inflammatory diseases
Other upcoming events for ZURA
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.